Related Experiment Video
Updated: Jun 16, 2026

08:29
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
Published on: October 10, 2012
The synchronous neural interactions test as a functional neuromarker for post-traumatic stress disorder (PTSD): a
A P Georgopoulos1, H-R M Tan, S M Lewis
1Brain Sciences Center, US Department of Veterans Affairs Medical Center (11B), Minneapolis, MN 55417, USA. omega@umn.edu
Journal of Neural Engineering
|January 21, 2010
Summary
Diagnosing post-traumatic stress disorder (PTSD) is challenging without a biomarker. A new synchronous neural interactions (SNI) test using magnetoencephalographic (MEG) recordings shows over 90% accuracy in differentiating PTSD patients from healthy individuals.
Area of Science:
- Neuroscience
- Psychiatry
- Biomarker Discovery
Background:
- Post-traumatic stress disorder (PTSD) is a debilitating condition resulting from traumatic experiences.
- Currently, no definitive biomarker exists for diagnosing PTSD, complicating assessment and treatment.
- Existing diagnostic methods rely on clinical evaluation, which can be subjective.
Purpose of the Study:
- To investigate the potential of the synchronous neural interactions (SNI) test as a diagnostic tool for PTSD.
- To determine if SNI, derived from magnetoencephalographic (MEG) recordings, can differentiate PTSD patients from healthy controls.
- To explore the utility of SNI for monitoring disease progression and treatment effects.
Main Methods:
- Utilized magnetoencephalographic (MEG) recordings to assess neural activity.
- Applied the synchronous neural interactions (SNI) test to analyze functional interactions among neural populations.
- Employed externally cross-validated, bootstrap-based analyses for classification accuracy assessment.
Main Results:
- The SNI test successfully differentiated PTSD patients from healthy control subjects with over 90% accuracy.
- The classification accuracy remained high even for patients not undergoing medication.
- Robust differences in brain function were identified between the PTSD and control groups.
Conclusions:
- The SNI test demonstrates significant potential as an objective biomarker for PTSD diagnosis.
- This neurophysiological approach offers a promising method for differential diagnosis of PTSD.
- SNI analysis may aid in assessing disease progression and the efficacy of therapeutic interventions.
